{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:32:08Z","timestamp":1792290728696,"version":"4.4.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.jgar.2018.11.025","type":"journal-article","created":{"date-parts":[[2018,12,14]],"date-time":"2018-12-14T14:48:59Z","timestamp":1544798939000},"page":"132-136","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":104,"special_numbering":"C","title":["Status of antimicrobial stewardship programmes in Nigerian tertiary healthcare facilities: Findings and implications"],"prefix":"10.1016","volume":"17","author":[{"given":"Joseph O.","family":"Fadare","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olayinka","family":"Ogunleye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8449-4674","authenticated-orcid":false,"given":"Garba","family":"Iliyasu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adekunle","family":"Adeoti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Schellack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deirdre","family":"Engler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amos","family":"Massele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6539-6972","authenticated-orcid":false,"given":"Brian","family":"Godman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgar.2018.11.025_bib0005","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1179\/2047773215Y.0000000030","article-title":"Antimicrobial resistance: a global multifaceted phenomenon","volume":"109","author":"Prestinaci","year":"2015","journal-title":"Pathog Glob Health"},{"key":"10.1016\/j.jgar.2018.11.025_bib0010","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3389\/fpubh.2014.00145","article-title":"The antimicrobial resistance crisis: causes, consequences, and management","volume":"2","author":"Michael","year":"2014","journal-title":"Front Public Health"},{"key":"10.1016\/j.jgar.2018.11.025_bib0015","unstructured":"O\u2019Neill J. Securing new drugs for future generations: the pipeline of antibiotics. The Review of Antimicrobial Resistance. https:\/\/amr-review.org\/sites\/default\/files\/SECURING%20NEW%20DRUGS%20FOR%20FUTURE%20GENERATIONS%20FINAL%20WEB_0.pdf. [Accessed 1 April 2019]."},{"key":"10.1016\/j.jgar.2018.11.025_bib0020","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.3855\/jidc.7695","article-title":"Antimicrobial resistance of selected invasive bacteria in a tertiary care center: results of a prospective surveillance study","volume":"10","author":"Djuric","year":"2016","journal-title":"J Infect Dev Ctries"},{"key":"10.1016\/j.jgar.2018.11.025_bib0025","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s10096-007-0321-5","article-title":"Antimicrobial use in Europe and antimicrobial resistance in Streptococcus pneumoniae","volume":"26","author":"Riedel","year":"2007","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jgar.2018.11.025_bib0030","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1128\/CMR.18.4.638-656.2005","article-title":"Antimicrobial stewardship programs in health care systems","volume":"18","author":"MacDougall","year":"2005","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jgar.2018.11.025_bib0035","article-title":"Interventions to improve antibiotic prescribing practices for hospital inpatients","volume":"2","author":"Davey","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jgar.2018.11.025_bib0040","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/S1473-3099(17)30344-4","article-title":"Antibiotic stewardship hits a home run for patients","volume":"17","author":"Goff","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jgar.2018.11.025_bib0045","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13017-017-0145-2","article-title":"The Global Alliance for Infections in Surgery: defining a model for antimicrobial stewardship\u2014results from an international cross-sectional survey","volume":"12","author":"Sartelli","year":"2017","journal-title":"World J Emerg Surg"},{"key":"10.1016\/j.jgar.2018.11.025_bib0050","first-page":"28","article-title":"SASOCP position statement on the pharmacist\u2019s role in antibiotic stewardship 2018","volume":"33","author":"Schellack","year":"2018","journal-title":"S Afr J Infect Dis"},{"key":"10.1016\/j.jgar.2018.11.025_bib0055","doi-asserted-by":"crossref","first-page":"430","DOI":"10.26719\/2017.23.6.430","article-title":"The impact of antimicrobial stewardship strategies on antibiotic appropriateness and prescribing behaviours in selected countries in the Middle East: a systematic review","volume":"23","author":"Nasr","year":"2017","journal-title":"East Mediterr Health J"},{"key":"10.1016\/j.jgar.2018.11.025_bib0060","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1080\/14787210.2017.1320220","article-title":"Compliance to guidelines for the prescribing of antibiotics in acute infections at Namibia\u2019s national referral hospital: a pilot study and the implications","volume":"15","author":"Nakwatumbah","year":"2017","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.jgar.2018.11.025_bib0065","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1086\/664909","article-title":"Antimicrobial stewardship at a large tertiary care academic medical center: cost analysis before, during, and after a 7-year program","volume":"33","author":"Standiford","year":"2012","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.jgar.2018.11.025_bib0070","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1086\/599172","article-title":"Antimicrobial stewardship programs in inpatient hospital settings: a systematic review","volume":"35","author":"Wagner","year":"2014","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.jgar.2018.11.025_bib0075","doi-asserted-by":"crossref","first-page":"547","DOI":"10.5144\/0256-4947.2013.547","article-title":"Antimicrobial stewardship program implementation in a medical intensive care unit at a tertiary care hospital in Saudi Arabia","volume":"33","author":"Amer","year":"2013","journal-title":"Ann Saudi Med"},{"key":"10.1016\/j.jgar.2018.11.025_bib0080","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1186\/s12913-016-1565-5","article-title":"A cost analysis of introducing an infectious disease specialist-guided antimicrobial stewardship in an area with relatively low prevalence of antimicrobial resistance","volume":"16","author":"Lanbeck","year":"2016","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.jgar.2018.11.025_bib0085","article-title":"Evaluation of the short-term effects of antimicrobial stewardship in the intensive care unit at a tertiary hospital in China","volume":"9","author":"Hou","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jgar.2018.11.025_bib0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0079747","article-title":"Antibiotic stewardship ward rounds and a dedicated prescription chart reduce antibiotic consumption and pharmacy costs without affecting inpatient mortality or re-admission rates","volume":"8","author":"Boyles","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jgar.2018.11.025_bib0095","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/tropej\/fmt111","article-title":"The use of unprescribed antibiotics in management of upper respiratory tract infection in children in Enugu, South East Nigeria","volume":"60","author":"Ekwochi","year":"2014","journal-title":"J Trop Pediatr"},{"key":"10.1016\/j.jgar.2018.11.025_bib0100","doi-asserted-by":"crossref","first-page":"73","DOI":"10.4314\/ejhs.v25i1.10","article-title":"Drug prescribing pattern for under-fives in a paediatric clinic in South-Western Nigeria","volume":"25","author":"Fadare","year":"2015","journal-title":"Ethiop J Health Sci"},{"key":"10.1016\/j.jgar.2018.11.025_bib0105","doi-asserted-by":"crossref","first-page":"344","DOI":"10.4103\/0300-1652.170378","article-title":"The influence of health insurance scheme on the drug prescribing pattern in a Nigerian tertiary healthcare facility","volume":"56","author":"Fadare","year":"2015","journal-title":"Niger Med J"},{"key":"10.1016\/j.jgar.2018.11.025_bib0110","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.cmi.2017.07.017","article-title":"Antibiotic stewardship: does it work in hospital practice? A review of the evidence base","volume":"23","author":"Hulscher","year":"2017","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jgar.2018.11.025_bib0115","doi-asserted-by":"crossref","first-page":"797","DOI":"10.4314\/ahs.v17i3.23","article-title":"Multidrug and vancomycin resistance among clinical isolates of Staphylococcus aureus from different teaching hospitals in Nigeria","volume":"17","author":"Olufunmiso","year":"2017","journal-title":"Afr Health Sci"},{"key":"10.1016\/j.jgar.2018.11.025_bib0120","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.ijantimicag.2017.07.002","article-title":"Antimicrobial resistance in West Africa: a systematic review and meta-analysis","volume":"50","author":"Bernabe","year":"2017","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jgar.2018.11.025_bib0125","doi-asserted-by":"crossref","first-page":"920","DOI":"10.3855\/jidc.7997","article-title":"Prevalence and multidrug resistance of Escherichia coli from community-acquired infections in Lagos, Nigeria","volume":"10","author":"Adenipekun","year":"2016","journal-title":"J Infect Dev Ctries"},{"key":"10.1016\/j.jgar.2018.11.025_bib0130","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1017\/ice.2016.115","article-title":"A concise set of structure and process indicators to assess and compare antimicrobial stewardship programs among EU and US hospitals: results from a multinational expert panel","volume":"37","author":"Pollack","year":"2016","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.jgar.2018.11.025_bib0135","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.3346\/jkms.2016.31.10.1553","article-title":"A survey of antimicrobial stewardship programs in Korea, 2015","volume":"31","author":"Kim","year":"2016","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.jgar.2018.11.025_bib0140","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1086\/675277","article-title":"Prevalence and characteristics of antimicrobial stewardship programs at freestanding children's hospitals in the United States","volume":"35","author":"Newland","year":"2014","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.jgar.2018.11.025_bib0145","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1017\/ice.2016.26","article-title":"Characteristics of antimicrobial stewardship programs at Veterans Affairs hospitals: results of a nationwide survey","volume":"37","author":"Chou","year":"2016","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.jgar.2018.11.025_bib0150","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1071\/AH13137","article-title":"Antimicrobial stewardship activities: a survey of Queensland hospitals","volume":"38","author":"Avent","year":"2014","journal-title":"Aust Health Rev"},{"key":"10.1016\/j.jgar.2018.11.025_bib0155","unstructured":"National Department of Health of South Africa. Antimicrobial resistance. National Strategy Framework 2014-2024. https:\/\/www.health-e.org.za\/wp-content\/uploads\/2015\/09\/Antimicrobial-Resistance-National-Strategy-Framework-2014-2024.pdf. [Accessed 1 April 2019]."},{"key":"10.1016\/j.jgar.2018.11.025_bib0160","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/phar.1590","article-title":"Impact of a stewardship-initiated restriction on empirical use of ciprofloxacin on nonsusceptibility of Escherichia coli urinary isolates to ciprofloxacin","volume":"35","author":"O\u2019Brien","year":"2015","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jgar.2018.11.025_bib0165","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/PCC.0000000000000615","article-title":"Reduction of broad-spectrum antimicrobial use in a tertiary children\u2019s hospital post antimicrobial stewardship program guideline implementation","volume":"17","author":"Lee","year":"2016","journal-title":"Pediatr Crit Care Med"},{"key":"10.1016\/j.jgar.2018.11.025_bib0170","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1002\/phar.1490","article-title":"Impact of an antimicrobial stewardship program on the use of carbapenems in a tertiary women\u2019s and children\u2019s hospital, Singapore","volume":"34","author":"Seah","year":"2014","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jgar.2018.11.025_bib0175","doi-asserted-by":"crossref","first-page":"E91","DOI":"10.1111\/1469-0691.12062","article-title":"Clinical impact of unsolicited post-prescription antibiotic review in surgical and medical wards: a randomized controlled trial","volume":"19","author":"Lesprit","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jgar.2018.11.025_bib0180","doi-asserted-by":"crossref","first-page":"802","DOI":"10.4314\/ahs.v14i4.5","article-title":"Pattern of pathogens from surgical wound infections in a Nigerian hospital and their antimicrobial susceptibility profiles","volume":"14","author":"Akinkunmi","year":"2014","journal-title":"Afr Health Sci"},{"key":"10.1016\/j.jgar.2018.11.025_bib0185","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jcrc.2016.04.018","article-title":"Nosocomial infections and resistance pattern of common bacterial isolates in an intensive care unit of a tertiary hospital in Nigeria: a 4-year review","volume":"34","author":"Iliyasu","year":"2016","journal-title":"J Crit Care"},{"key":"10.1016\/j.jgar.2018.11.025_bib0190","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12941-016-0135-3","article-title":"Comparison of Clinical Laboratory Standards Institute and European Committee on Antimicrobial Susceptibility Testing guidelines for the interpretation of antibiotic susceptibility at a university teaching hospital in Nairobi, Kenya: a cross-sectional study","volume":"15","author":"Kassim","year":"2016","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"10.1016\/j.jgar.2018.11.025_bib0195","doi-asserted-by":"crossref","first-page":"751","DOI":"10.3389\/fphar.2017.00751","article-title":"Ongoing initiatives to improve the quality and efficiency of medicine use within the public healthcare system in South Africa; a preliminary study","volume":"8","author":"Meyer","year":"2017","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jgar.2018.11.025_bib0200","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1080\/14787210.2018.1467756","article-title":"Ongoing initiatives to improve the use of antibiotics in Botswana: University of Botswana symposium meeting report","volume":"16","author":"Tiroyakgosi","year":"2018","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.jgar.2018.11.025_bib0205","first-page":"3","article-title":"Determinants of the effectiveness of antimicrobial prophylaxis among neurotrauma patients at a referral hospital in Kenya: findings and implications","volume":"5","author":"Opanga","year":"2017","journal-title":"J Infect Dis Prev Med"},{"key":"10.1016\/j.jgar.2018.11.025_bib0210","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/21548331.2018.1450605","article-title":"Prophylactic antibiotics to prevent surgical site infections in Botswana: findings and implications","volume":"46","author":"Mwita","year":"2018","journal-title":"Hosp Pract"},{"key":"10.1016\/j.jgar.2018.11.025_bib0215","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1586\/14737167.2015.1088386","article-title":"Outcome of the first Medicines Utilization Research in Africa group meeting to promote sustainable and rational medicine use in Africa","volume":"15","author":"Massele","year":"2015","journal-title":"Expert Rev Pharmacoeconom Outcomes Res"},{"key":"10.1016\/j.jgar.2018.11.025_bib0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1586\/14737167.2016.1164040","article-title":"Research activities to improve the utilization of antibiotics in Africa","volume":"17","author":"Massele","year":"2017","journal-title":"Expert Review Pharmacoeconom Outcomes Res"},{"key":"10.1016\/j.jgar.2018.11.025_bib0225","doi-asserted-by":"crossref","first-page":"e619","DOI":"10.1016\/S2214-109X(18)30186-4","article-title":"Antimicrobial consumption and resistance in adult hospital inpatients in 53 countries: results of an internet-based global point prevalence survey","volume":"6","author":"Versporten","year":"2018","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.jgar.2018.11.025_bib0230","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1080\/21548331.2019.1592880","article-title":"Feasibility of using point prevalence surveys to assess antimicrobial utilisation in public hospitals in South Africa: a pilot study and implications","volume":"47","author":"Dlamini","year":"2019","journal-title":"Hosp Pract"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221371651830242X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221371651830242X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,18]],"date-time":"2019-06-18T16:46:55Z","timestamp":1560876415000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221371651830242X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":46,"alternative-id":["S221371651830242X"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2018.11.025","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Status of antimicrobial stewardship programmes in Nigerian tertiary healthcare facilities: Findings and implications","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2018.11.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 International Society for Chemotherapy of Infection and Cancer. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}